STAAR Surgical (STAA) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
STAAR Surgical Reports Second Quarter 2016 Results
August 3, 2016 4:01 PM EDTMONROVIA, Calif., Aug. 3, 2016 /PRNewswire/ --Â STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the second quarter ended July 1, 2016.
Second Quarter 2016 Overview
Record Quarterly Net Sales of $21.0 Million Up 12% from the Prior Year Quarter Worldwide ICL Sales Up 26% and Units Up 18% from the Prior Year Quarter Worldwide IOL Sales Down 3% and Units Down 15% from the Prior Year Quarter Gross Margin Improved to 69.7% of... More


